Point72 Asset Management
SLRN

Point72 Asset Management’s ACELYRIN SLRN Stock Holding History

Point72 Asset Management’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-250,300
Closed -$1.23M – 2424
2024
Q3 		$1.23M Buy
250,300
+212,758
+567% +$1.1M ﹤0.01% 1348
2024
Q2 		$166K Sell
37,542
-185,958
-83% -$872K ﹤0.01% 1645
2024
Q1 		$1.51M Sell
223,500
-221,492
-50% -$1.68M ﹤0.01% 1355
2023
Q4 		$3.32M Buy
444,992
+286,192
+180% +$2.44M 0.01% 1057
2023
Q3 		$1.61M Buy
+158,800
New +$3.37M ﹤0.01% 1194

Other funds holding SLRN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACMC
AyurMaya Capital Management Company Portsmouth, New Hampshire $148M AUM 24.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Point72 Asset Management's SLRN Position: Q4 2024 in Review

Point72 Asset Management sold out of ACELYRIN (SLRN) in Q4 2024, closing a stake of 250,300 shares — an estimated $1.23M sold.

Point72 Asset Management first reported a position in SLRN in Q3 2023 and held it in 5 quarters. The position peaked at $3.32M in Q4 2023. 125 funds tracked by Wall St. Rank hold SLRN as of Q4 2024.

  • Point72 Asset Management reported no remaining ACELYRIN position as of Q4 2024 after selling out during the quarter.
  • Point72 Asset Management sold 250,300 ACELYRIN shares in Q4 2024, an estimated $1.23M.
  • Point72 Asset Management first reported a position in ACELYRIN in Q3 2023 and held it in 5 quarters.
  • Point72 Asset Management's ACELYRIN position peaked at $3.32M in Q4 2023.
  • 125 funds tracked by Wall St. Rank held ACELYRIN as of Q4 2024.

Based on Point72 Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.